Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Zhongwen Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Lishui University, Lishui, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Saponins, Oleanolic Acid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Joint Fund of Zhejiang Provincial Natural Science Foundation of China, Lishui University.
Abstract (Originalsprache)
Saikosaponin A (SSa) is an oleanane type triterpenoid saponin isolated from Radix Bupleuri ( Bupleurum chinense DC). While SSa has demonstrated significant pharmacological activities including anti‐inflammatory, antioxidant, and antidepressant effects, its pharmacokinetic profile remains poorly characterized. This study developed and validated a sensitive LC–MS/MS method for quantifying SSa in rat plasma. After acetonitrile‐mediated protein precipitation, SSa and the internal standard (IS) were separated on a Waters Acquity BEH C18 column using MS detection operated in negative multiple reaction monitoring (MRM) mode. The assay was linear over the concentration range of 2–1000 ng/mL with satisfactory validation parameters of intra‐and inter‐day precision (3.50%–10.01%) and accuracy (−5.93% to −2.68%), extraction recovery (73.75%–82.50%), stability, and matrix effect (88.49%–103.64%). Application in pharmacokinetic studies revealed distinct administration‐related characteristics. Intravenous administration (5 mg/kg) resulted in high clearance with an elimination half‐life ( t 1/2 ) of 2.29 h and was accompanied by hemolysis. Oral administration at doses of 50, 100, and 200 mg/kg showed dose‐dependent systemic exposure with consistently low bioavailability (0.04%). The limited absorption is likely attributable to poor gastrointestinal permeability and extensive metabolism mediated by intestinal microbiota and hepatic first‐pass effects, as indicated by the extremely low system exposure. These findings provide useful information for optimizing SSa therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, Lishui University, Lishui, China.
- Xuzhou Medical University, Xuzhou, China.
ORCID-Profile: Zhongwen Sun
Förderung
- Joint Fund of Zhejiang Provincial Natural Science Foundation of China
- Lishui University
Zitieren
APA
Sun, Z., Qiu, C., An, Y., Yan, Z., & Li, C. (2025). Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method. Biomedical Chromatography. https://doi.org/10.1002/bmc.70219
Vancouver
Sun Z, Qiu C, An Y, Yan Z, Li C. Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method. Biomedical Chromatography. 2025. doi:10.1002/bmc.70219
BibTeX
@article{Sun2025,
author = {Sun, Zhongwen and Qiu, Chao and An, Yiqiang and Yan, Zhengyuan and Li, Caifu},
title = {Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70219}
}
EUVIMED